镁锌钙合金(ZX00)螺钉在内踝骨折固定后平均2.5年吸收:首次人体应用随访及绵羊模型见解
本研究通过绵羊模型(18枚不同长度ZX00螺钉与6枚钛合金螺钉对比)和首次人体研究(20例内踝骨折患者),评估ZX00镁合金螺钉的骨吸收行为与临床结局。绵羊模型显示25个月时螺钉降解至原始体积的1/3,无不良免疫反应;患者平均随访2.5年,18例中17例X线不可见植入物,无临床并发症。
要点
- 绵羊模型中ZX00螺钉25个月降解至原始体积的1/3,组织学示持续吸收伴新骨形成,无炎症反应
- 内踝骨折患者平均2.5年随访,18例中17例X线不可见植入物,15例骨质地均匀
- 无临床或患者报告并发症,踝关节功能无痛
核心结论
- 绵羊模型中ZX00螺钉25个月吸收至原始体积的1/3,未引发不良免疫反应,支持该期间生物相容性
- 患者平均2.5年X线不可检测植入物,提示完全吸收,但需进一步研究评估植入物吸收后植入部位骨质量的环境变化
研究设计与样本
- 绵羊模型:18枚不同长度(29 mm、24 mm、16 mm)ZX00螺钉植入胫骨,与6枚钛合金螺钉对比,13和25个月行Micro-CT及组织学评估
- 首次人体研究:2018年7月至2019年10月,20例内踝骨折患者接受ZX00螺钉治疗,随访时间平均2.5±0.6年,中位2.4年(范围18至43个月)
主要发现
- 绵羊模型13个月:29 mm螺钉(初始体积198±1 mm³)降解41%(116±6 mm³,平均差82 [95%CI 71至92];p<0.001);25个月降解65%(69±7 mm³,平均差130 [95%CI 117至142];p<0.001)
- 绵羊模型13个月:24 mm螺钉(初始体积174±0.2 mm³)降解51%(86±21 mm³,平均差88 [95%CI 52至123];p=0.004);25个月降解72%(49±25 mm³,平均差125 [95%CI 83至167];p=0.003)
- 绵羊模型13个月:16 mm螺钉(初始体积112±5 mm³)降解57%(49±8 mm³,平均差63 [95%CI 50至76];p<0.001);25个月降解61%(45±10 mm³,平均差67 [95%CI 52至82];p<0.001)
- 组织学定性显示持续吸收伴新骨形成紧密连接吸收中的螺钉,无炎症反应
- 患者平均2.5年:18例中17例X线不可见植入物,15例骨质地均匀,无临床或患者报告并发症
临床怎么用
- 作者认为ZX00螺钉可用于内踝骨折固定,实现无临床并发症或翻修手术的愈合,2.5年后踝关节功能无痛
- 作者建议未来需开展更大样本、更长随访的前瞻性研究,以全面评估ZX00螺钉的长期有效性和安全性,包括探索骨完整性改变(如骨质疏松)时的局限性
- 作者建议额外使用先进影像技术(如高分辨率CT)可提高评估准确性
局限性
- 需进一步研究评估植入物吸收后植入部位骨质量的环境变化
- 未来需更大样本和更长随访的前瞻性研究以全面评估长期有效性和安全性
- 需探索骨完整性改变(如骨质疏松)时的局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In the ongoing development of bioresorbable implants, there has been a particular focus on magnesium (Mg)-based alloys. Several Mg alloys have shown promising properties, including a lean, bioresorbable magnesium-zinc-calcium (Mg-Zn-Ca) alloy designated as ZX00. To our knowledge, this is the first clinically tested Mg-based alloy free from rare-earth elements or other elements. Its use in medial malleolar fractures has allowed for bone healing without requiring surgical removal. It is thus of interest to assess the resorption behavior of this novel bioresorbable implant. QUESTIONS/PURPOSES: (1) What is the behavior of implanted Mg-alloy (ZX00) screws in terms of resorption (implant volume, implant surface, and gas volume) and bone response (histologic evaluation) in a sheep model after 13 months and 25 months? (2) What are the radiographic changes and clinical outcomes, including patient-reported outcome measures, at a mean of 2.5 years after Mg-alloy (ZX00) screw fixation in patients with medial malleolar fractures? METHODS: A sheep model was used to assess 18 Mg-alloy (ZX00) different-length screws (29 mm, 24 mm, and 16 mm) implanted in the tibiae and compared with six titanium-alloy screws. Micro-CT was performed at 13 and 25 months to quantify the implant volume, implant surface, and gas volume at the implant sites, as well as histology at both timepoints. Between July 2018 and October 2019, we treated 20 patients with ZX00 screws for medial malleolar fractures in a first-in-humans study. We considered isolated, bimalleolar, or trimalleolar fractures potentially eligible. Thus, 20 patients were eligible for follow-up. However, 5% (one patient) of patients were excluded from the analysis because of an unplanned surgery for a pre-existing osteochondral lesion of the talus performed 17 months after ZX00 implantation. Additionally, another 5% (one patient) of patients were lost before reaching the minimum study follow-up period. Our required minimum follow-up period was 18 months to ensure sufficient time to observe the outcomes of interest. At this timepoint, 10% (two patients) of patients were either missing or lost to follow-up. The follow-up time was a mean of 2.5 ± 0.6 years and a median of 2.4 years (range 18 to 43 months). RESULTS: In this sheep model, after 13 months, the 29-mm screws (initial volume: 198 ± 1 mm 3 ) degraded by 41% (116 ± 6 mm 3 , mean difference 82 [95% CI 71 to 92]; p < 0.001), and after 25 months by 65% (69 ± 7 mm 3 , mean difference 130 [95% CI 117 to 142]; p < 0.001). After 13 months, the 24-mm screws (initial volume: 174 ± 0.2 mm 3 ) degraded by 51% (86 ± 21 mm 3 , mean difference 88 [95% CI 52 to 123]; p = 0.004), and after 25 months by 72% (49 ± 25 mm 3 , mean difference 125 [95% CI 83 to 167]; p = 0.003). After 13 months, the 16-mm screws (initial volume: 112 ± 5 mm 3 ) degraded by 57% (49 ± 8 mm 3 , mean difference 63 [95% CI 50 to 76]; p < 0.001), and after 25 months by 61% (45 ± 10 mm 3 , mean difference 67 [95% CI 52 to 82]; p < 0.001). Histologic evaluation qualitatively showed ongoing resorption with new bone formation closely connected to the resorbing screw without an inflammatory reaction. In patients treated with Mg-alloy screws after a mean of 2.5 years, the implants were radiographically not visible in 17 of 18 patients and the bone had homogenous texture in 15 of 18 patients. No clinical or patient-reported complications were observed. CONCLUSION: In this sheep model, Mg-alloy (ZX00) screws showed a resorption to one-third of the original volume after 25 months, without eliciting adverse immunologic reactions, supporting biocompatibility during this period. Mg-alloy (ZX00) implants were not detectable on radiographs after a mean of 2.5 years, suggesting full resorption, but further studies are needed to assess environmental changes regarding bone quality at the implantation site after implant resorption. CLINICAL RELEVANCE: The study demonstrated successful healing of medial malleolar fractures using bioresorbable Mg-alloy screws without clinical complications or revision surgery, resulting in pain-free ankle function after 2.5 years. Future prospective studies with larger samples and extended follow-up periods are necessary to comprehensively assess the long-term effectiveness and safety of ZX00 screws, including an exploration of limitations when there is altered bone integrity, such as in those with osteoporosis. Additional use of advanced imaging techniques, such as high-resolution CT, can enhance evaluation accuracy.
引用
- Labmayr V, Suljevic O, Sommer NG, et al. Mg-Zn-Ca Alloy (ZX00) Screws Are Resorbed at a Mean of 2.5 Years After Medial Malleolar Fracture Fixation: Follow-up of a First-in-humans Application and Insights From a Sheep Model. Clin Orthop Relat Res. 2023. PMID: 37603369. doi:10.1097/CORR.0000000000002799
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。